Loading…
Chinese medical-imaging equipment maker producing X-ray and digital radiography systems for hospitals.
Chinese medical-imaging equipment maker producing X-ray and digital radiography systems for hospitals.
Sells to hospitals and clinics, often through tenders, and gets repeat income from service and spare parts on its installed machines. Now controlled by Jiangsu Yuyue Medical, a household and hospital medical-device maker.
In one line: A Chinese GE Healthcare/Canon Medical for X-ray imaging.
Moat: narrow (installed base, brand). Long domestic imaging-equipment heritage and hospital installed base.
Headquarters: Beijing, China · Employees: 1,215
Size Beijing Wandong Medical Technology (600055.SS) is a China Health Care company (Medical Specialties) with a market value of $1.11B, the 2105th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.58 on 6 Nov 2026.
Performance Over six months the shares fell 26.8%, against -3.6% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 20 in its peer set.
Growth Revenue fell 10.9% over the last twelve months (peer median +13.7%); the operating margin is -32.6% (peer median 8.6%).
Valuation It trades at 3.4× enterprise value to sales against a peer median of 4.5× (9th cheapest of 20).
Capital Return on invested capital runs 24.8 points below its cost of capital (7.2% WACC).
Next results Next results expected around 16 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.43B | CN¥1.34B | CN¥1.51B | CN¥1.22B | CN¥1.11B |
| Revenue growth | — | -11% | +23% | +11% | — |
| Gross profit | CN¥304M | CN¥325M | CN¥522M | CN¥495M | CN¥463M |
| EBITDA | n/a | -CN¥322M | CN¥109M | CN¥81.8M | CN¥127M |
| Net income | -CN¥345M | -CN¥228M | CN¥157M | CN¥189M | CN¥175M |
| Free cash flow | -CN¥168M | -CN¥351M | CN¥180M | CN¥201M | CN¥193M |
| Capital expenditure | CN¥109M | CN¥99.0M | CN¥38.6M | CN¥17.1M | CN¥14.0M |
| Total debt | CN¥222M | CN¥438M | CN¥101M | CN¥88.2M | CN¥52.8M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Beijing Wandong Medical Technology 600055.SS | $1.11B | -27% | -11% | -33% | 3.4× | n/a |
| GE HealthCare GEHC | $37.2B | +30% | +7% | 14% | 2.1× | 4.3% |
| Shanghai United Imaging Healthcare 688271.SS | $14.8B | +9% | +27% | 9% | 6.2× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 600055.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.9% | +0.3% | 10th highest of 21 |
| 6-month return | -26.8% | -3.6% | 2nd lowest of 20 |
| Distance from 52-week high | -42.0% | -33.6% | 8th lowest of 21 |
| Revenue growth (TTM) | -10.9% | +13.7% | lowest of 20 |
| Operating margin | -32.6% | 8.6% | 4th lowest of 20 |
| EV / Sales | 3.4× | 4.5× | 9th cheapest of 20 |
| ROIC minus cost of capital | -24.8 pp | -4.8 pp | 2nd lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Beijing Wandong Medical Technology 600055.SS | China | $1.11B | -27% | -11% | -33% | 3.4× | n/a | n/a |
| IRadimed IRMD | United States | $1.10B | 0% | +11% | 32% | 11.7× | 19.1% | +21.5% |
| Amoy Diagnostics 300685.SZ | China | $1.10B | -14% | +7% | 34% | 5.2× | 6.5% | +10.3% |
| Freenome FRNM | United States | $1.09B | n/a | n/a | n/a | n/a | n/a | n/a |
| SI-BONE SIBN | United States | $1.09B | +98% | +14% | -8% | 4.5× | n/a | n/a |
| Beijing Strong Biotechnologies 300406.SZ | China | $1.13B | +1% | -4% | 36% | 5.8× | 1.5% | +9.9% |
| PHC 6523.T | Japan | $1.09B | +36% | +3% | 7% | 1.0× | -2.3% | +3.6% |
| Tinavi Medical Technologies 688277.SS | China | $1.08B | -30% | -2% | -59% | 26.9× | n/a | n/a |
| INKON Life Technology 300143.SZ | China | $1.08B | -14% | +22% | 12% | 3.4× | 12.4% | +12.9% |
| Mingyue Optical Lens 301101.SZ | China | $1.14B | +6% | +14% | 25% | 6.8× | 10.0% | +8.8% |
| L&C BIO 290650.KS | South Korea | $1.07B | -17% | +53% | 17% | 12.8× | n/a | n/a |
| Alphatec ATEC | United States | $1.15B | -1% | +15% | -3% | 2.0× | n/a | n/a |
| Inno Laser Technology 301021.SZ | China | $1.16B | -18% | +17% | 9% | 12.7× | 53.9% | +8.6% |
| Edan Instruments 300206.SZ | China | $1.05B | -19% | +14% | 17% | 2.7× | 7.7% | -2.9% |
| Integra LifeSciences IART | United States | $1.04B | -4% | +1% | 12% | 1.6× | 5.2% | +3.6% |
| Tandem Diabetes Care TNDM | United States | $1.18B | +9% | +4% | -4% | 1.4× | n/a | n/a |
| PROCEPT BioRobotics PRCT | United States | $1.18B | -19% | +23% | -34% | 3.0× | n/a | n/a |
| Ceribell CBLL | United States | $1.03B | +32% | +31% | -70% | 8.6× | n/a | n/a |
| Castle Biosciences CSTL | United States | $993M | +64% | +3% | -9% | 2.1× | n/a | n/a |
| Shandong Weigao Orthopaedic Device 688161.SS | China | $1.24B | -25% | -6% | 18% | 5.1× | 12.7% | -3.5% |
| Artivion AORT | United States | $985M | -20% | +16% | 7% | 2.8× | n/a | n/a |